JOHNSON & JOHNSON (JNJ)
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
Smithfield® and Pabst Blue Ribbon Kick Off Grilling Season with a Bold New Beer Brat
BWXT Begins NRC Engagement on Licensing for a New Defense Nuclear Fuel Facility
Adient to discuss Q2 fiscal 2026 financial results on May 6, 2026
AV’s UES Awarded $25M AFRL Contract to Mature Human Performance Technologies for Warfighter Readiness
North American Construction Group Closes Strategic Acquisition of Iron Mine Contracting, a Diversified Mining Services Contractor
Openreach Uses NiCE Cognigy AI Agents to Upgrade U.K. Broadband Deployment to Deliver Tens of Millions in Financial Benefits for Openreach and its Clients
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension
Beyond Oil Reports Financial Results for Fourth Quarter and Full-Year 2025
Vishay Precision Group Announces Date for Its First Quarter Fiscal 2026 Earnings Conference Call
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Micropolis to Participate in Maxim Group’s AI Infrastructure Virtual Conference on April 7, 2026
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
Riskified Partners with Outpayce from Amadeus to Enable and Secure Payments for Airlines and Travel Merchants Worldwide